Hughes J - Search Results

1

The CCK-B antagonist CI988 enhances the reflex-depressive effect of morphine in axotomized rats.

Xu XJ, Hökfelt T, Hughes J, Wiesenfeld-Hallin Z. Xu XJ, et al. Among authors: hughes j. Neuroreport. 1994 Feb 24;5(6):718-20. doi: 10.1097/00001756-199402000-00015. Neuroreport. 1994. PMID: 8199346

2

CI988, a selective antagonist of cholecystokininB receptors, prevents morphine tolerance in the rat.

Xu XJ, Wiesenfeld-Hallin Z, Hughes J, Horwell DC, Hökfelt T. Xu XJ, et al. Among authors: hughes j. Br J Pharmacol. 1992 Mar;105(3):591-6. doi: 10.1111/j.1476-5381.1992.tb09024.x. Br J Pharmacol. 1992. PMID: 1628146 Free PMC article.

3

PD134308, a selective antagonist of cholecystokinin type B receptor, enhances the analgesic effect of morphine and synergistically interacts with intrathecal galanin to depress spinal nociceptive reflexes.

Wiesenfeld-Hallin Z, Xu XJ, Hughes J, Horwell DC, Hökfelt T. Wiesenfeld-Hallin Z, et al. Among authors: hughes j. Proc Natl Acad Sci U S A. 1990 Sep;87(18):7105-9. doi: 10.1073/pnas.87.18.7105. Proc Natl Acad Sci U S A. 1990. PMID: 1698290 Free PMC article.

4

Studies on the effect of systemic PD134308 (CAM 958) in spinal reflex and pain models with special reference to interaction with morphine and intrathecal galanin.

Wiesenfeld-Hallin Z, Xu XJ, Hughes J, Horwell DC, Hökfelt T. Wiesenfeld-Hallin Z, et al. Among authors: hughes j. Neuropeptides. 1991 Jul;19 Suppl:79-84. doi: 10.1016/0143-4179(91)90086-x. Neuropeptides. 1991. PMID: 1715529

5

Modulation of striatal aspartate and dynorphin B release by cholecystokinin (CCK-8) studied in vivo with microdialysis.

You ZB, Pettersson E, Herrera-Marschitz M, Hökfelt T, Terenius L, Nylander I, Goiny M, Hughes J, O'Connor WT, Ungerstedt U. You ZB, et al. Among authors: hughes j. Neuroreport. 1994 Nov 21;5(17):2301-4. doi: 10.1097/00001756-199411000-00024. Neuroreport. 1994. PMID: 7881050

6

Up-regulation of cholecystokinin in primary sensory neurons is associated with morphine insensitivity in experimental neuropathic pain in the rat.

Xu XJ, Puke MJ, Verge VM, Wiesenfeld-Hallin Z, Hughes J, Hökfelt T. Xu XJ, et al. Among authors: hughes j. Neurosci Lett. 1993 Apr 2;152(1-2):129-32. doi: 10.1016/0304-3940(93)90500-k. Neurosci Lett. 1993. PMID: 8515864

7

Evidence for aspartate-immunoreactive neurons in the neostriatum of the rat: modulation by the mesencephalic dopamine pathway via D1-subtype of receptor.

Pettersson E, Herrera-Marschitz M, Rodriguez-Puertas R, Xu ZQ, You ZB, Hughes J, Elde RP, Ungerstedt U, Hökfelt T. Pettersson E, et al. Among authors: hughes j. Neuroscience. 1996 Sep;74(1):51-66. doi: 10.1016/0306-4522(96)00124-8. Neuroscience. 1996. PMID: 8843077

8

Anxiolytic effects of CCK-B antagonists.

Costall B, Domeney AM, Hughes J, Kelly ME, Naylor RJ, Woodruff GN. Costall B, et al. Among authors: hughes j. Neuropeptides. 1991 Jul;19 Suppl:65-73. doi: 10.1016/0143-4179(91)90084-v. Neuropeptides. 1991. PMID: 1679211

9

The antagonism of benzodiazepine withdrawal effects by the selective cholecystokininB receptor antagonist CI-988.

Singh L, Field MJ, Vass CA, Hughes J, Woodruff GN. Singh L, et al. Among authors: hughes j. Br J Pharmacol. 1992 Jan;105(1):8-10. doi: 10.1111/j.1476-5381.1992.tb14201.x. Br J Pharmacol. 1992. PMID: 1350747 Free PMC article.

10

Functional role of brain CCK receptors.

Woodruff GN, Hill DR, Boden P, Pinnock R, Singh L, Hughes J. Woodruff GN, et al. Among authors: hughes j. Neuropeptides. 1991 Jul;19 Suppl:45-56. doi: 10.1016/0143-4179(91)90082-t. Neuropeptides. 1991. PMID: 1881532 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

6,923 results

Search Page